Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

Roche submits filing to FDA for cobas® Procalcitonin (PCT) assay to help clinicians assess response of septic patients to treatment

PR Newswire March 23, 2016

FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis

PR Newswire March 21, 2016

FDA Grants Genentech's Cancer Immunotherapy Atezolizumab Priority Review for Advanced Bladder Cancer

Business Wire March 15, 2016

Roche launches new chromogen for cancer research

PR Newswire March 11, 2016

Roche receives China Food and Drug Administration (CFDA) approval for the CINtec® PLUS Cytology test to help prevent women from developing cervical cancer

PR Newswire March 8, 2016

Timing is Crucial, Upside Analysis - Complementary Research on Terra Tech, Roche Holding, Gold Reserve and Bayer

Accesswire March 3, 2016

Roche submits filing to FDA for HbA1c testing solution to help meet increasing demand for HbA1c testing of people with diabetes

PR Newswire March 2, 2016

FDA Files Genentech's Supplemental Biologics License Application of Xolair® (omalizumab) for Pediatric Allergic Asthma

Business Wire March 1, 2016

GENENTECH PROVIDES UPDATE ON TWO IDENTICAL PHASE III STUDIES OF LEBRIKIZUMAB IN PEOPLE WITH SEVERE ASTHMA

Business Wire February 29, 2016

FDA Approves Genentech's Gazyva® (Obinutuzumab) for Certain People with Previously Treated Follicular Lymphoma

Business Wire February 26, 2016

FDA Grants Breakthrough Therapy Designation for Genentech's Ocrelizumab in Primary Progressive MS

Press Releases February 17, 2016

FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis

Press Releases February 17, 2016

Latest developments in cancer research and treatment explored by top global scientists at Tucson Symposium

PR Newswire February 8, 2016

Updated cervical cancer screening guidelines from leading ob-gyn society support expanded use of cobas HPV Test for primary screening

PR Newswire February 1, 2016

FDA GRANTS PRIORITY REVIEW FOR VENETOCLAX NEW DRUG APPLICATION

Business Wire January 12, 2016

New Roche HBV Test expands cobas® 4800 System menu

PR Newswire December 22, 2015

Roche receives FDA approval for HIV-1 viral load test on the cobas® 6800/8800 Systems

PR Newswire December 21, 2015

Roche Submits Anti-Mullerian Hormone Assay for FDA Approval

PR Newswire December 17, 2015

FDA Grants Genentech's Alecensa® (Alectinib) Accelerated Approval for People with a Specific Type of Lung Cancer

Business Wire December 11, 2015

Roche finalizes acquisition of Kapa Biosystems to strengthen next-generation sequencing product offerings

PR Newswire December 8, 2015